The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
It was learned from implant patient registry that a 27mm 11400m mitris resilia mitral valve was explanted after an implant duration of 3 days due to valve dehiscence secondary to preexisting endocarditis.The explanted valve was replaced with a 27mm 11400m mitris resilia mitral valve.Per medical records, the patient is s/p mvr for endocarditis.On post implant day #1, the patient suffered a pea arrest requiring cpr.Rosc was achieved within 5-7 minutes.Tee showed la dissection and dehiscence of the newly implanted valve with a paravalvular leak into the false lumen of the dissection.The patient underwent thoracic washout.On post implant day # 2, the patient underwent redo mvr utilizing a 27mm 11400m mitris resilia mitral valve, posterior mitral annulus reconstruction.Her post operative tee showed normally functioning replacement valve with no pvl.Postoperative hospital course was complicated by atrial flutter that was treated medically and converted to nsr with a first degree av block on pod# 25.The patient was discharged to an acute rehabilitation facility on pod# 32 in stable condition.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional customer complaint.The information reported may or may not be related to the edwards device.
|
The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Device dehiscence may occur early or late.When it occurs in the early post-operative period, it is typically a result of inadequate device implantation in combination with friable myocardial tissue.Late dehiscence can occur as a result of successive dilatation of cardiac structures that result from progression of disease.Valve dehiscence is not a malfunction of the device.Through further investigation, it was determined that the root cause of this event was most likely due to patient related factors.
|